Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 63Neoplasms 36Colorectal Neoplasms 34Neoplasm Metastasis 32Ovarian Neoplasms 26Breast Neoplasms 26Recurrence 25Prostatic Neoplasms 25Pancreatic Neoplasms 25Melanoma 24Squamous Cell Carcinoma of Head and Neck 21Multiple Myeloma 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Lung Neoplasms 18Glioblastoma 18Endometrial Neoplasms 16Triple Negative Breast Neoplasms 15Lymphoma, Non-Hodgkin 15Lymphoma, Large B-Cell, Diffuse 15Burkitt Lymphoma 14Stomach Neoplasms 13Leukemia, Myeloid, Acute 13Colonic Neoplasms 13Small Cell Lung Carcinoma 12Glioma 12Carcinoma, Renal Cell 12Sarcoma 11Gastrointestinal Neoplasms 11Lymphoma, Follicular 10Lymphoma 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Adenoviridae Infections × 30 days × Clear all
NCT04364178 2026-05-27

Viral Specific T-Lymphocytes to Treat Adenovirus, CMV and EBV

Stanford University

Phase 1/2 Terminated
8 enrolled 14 charts

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡